Evidence map›Paper›PMID 29426339›Full record

ArticleBMC health services research2018

Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany.

Ana Babac, Martin Frank, Frédéric Pauer, Svenja Litzkendorf, Daniel Rosenfeldt, Verena Lührs, Lisa Biehl, Tobias Hartz, Holger Storf, Franziska Schauer and 2 more

Abstract read
In one paragraph

Article in BMC health services research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Beyond the ICU: family resilience and emotional turmoil after intensive care - a qualitative study.International journal of qualitative studies on health and well-being · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ana BabacCHERH - Centre for Health Economics Research Hannover, Leibniz University Hannover, Otto-Brenner-Straße 1, 30159, Hannover, Germany. ab@cherh.de.ORCID 0000-0002-0210-5370
Martin FrankCHERH - Centre for Health Economics Research Hannover, Leibniz University Hannover, Otto-Brenner-Straße 1, 30159, Hannover, Germany.
Frédéric PauerCHERH - Centre for Health Economics Research Hannover, Leibniz University Hannover, Otto-Brenner-Straße 1, 30159, Hannover, Germany.
Svenja LitzkendorfCHERH - Centre for Health Economics Research Hannover, Leibniz University Hannover, Otto-Brenner-Straße 1, 30159, Hannover, Germany.
Daniel RosenfeldtCHERH - Centre for Health Economics Research Hannover, Leibniz University Hannover, Otto-Brenner-Straße 1, 30159, Hannover, Germany.
Verena LührsZQ - Centre for Quality and Management in Healthcare, Medical Association of Lower Saxony, Berliner Allee 20, 30175, Hannover, Germany.
Lisa BiehlACHSE - Alliance for Chronic Rare Diseases, DRK-Clinics Berlin, Drontheimer Straße 39, 13359, Berlin, Germany.
Tobias HartzIMBEI - Institute for Medical Biometry, Epidemiology and Informatics, Obere Zahlbacher Str. 69, 55131, Mainz, Germany.
Holger StorfIMBEI - Institute for Medical Biometry, Epidemiology and Informatics, Obere Zahlbacher Str. 69, 55131, Mainz, Germany.
Franziska SchauerDepartment of Dermatology, Freiburg Center for Rare Diseases, University Medical Center, University of Freiburg, Hauptstraße 7, 79104, Freiburg, Germany.
Thomas O F WagnerUniversity Centre for Thorax Oncology, University Clinic of the Johann Wolfgang-Goethe University, Theodor-Stern-Kai 7, 60559, Frankfurt am Main, Germany.
J-Matthias Graf von der SchulenburgCHERH - Centre for Health Economics Research Hannover, Leibniz University Hannover, Otto-Brenner-Straße 1, 30159, Hannover, Germany.

Funding

Bundesministerium für Gesundheit IIA5-2513FSB801
6 · The paper itself

Abstract

backgroundRare diseases are, by definition, very serious and chronic diseases with a high negative impact on quality of life. Approximately 350 million people worldwide live with rare diseases. The resulting high disease burden triggers health information search, but helpful, high-quality, and up-to-date information is often hard to find. Therefore, the improvement of health information provision has been integrated in many national plans for rare diseases, discussing the telephone as one access option. In this context, this study examines the need for a telephone service offering information for people affected by rare diseases, their relatives, and physicians.

methodsIn total, 107 individuals participated in a qualitative interview study conducted in Germany. Sixty-eight individuals suffering from a rare disease or related to somebody with rare diseases and 39 health care professionals took part. Individual interviews were conducted using a standardized semi-structured questionnaire. Interviews were analysed using the qualitative content analysis, triangulating patients, relatives, and health care professionals. The fulfilment of qualitative data processing standards has been controlled for.

resultsOut of 68 patients and relatives and 39 physicians, 52 and 18, respectively, advocated for the establishment of a rare diseases telephone service. Interviewees expected a helpline to include expert staffing, personal contact, good availability, low technical barriers, medical and psychosocial topics of counselling, guidance in reducing information chaos, and referrals. Health care professionals highlighted the importance of medical topics of counselling-in particular, differential diagnostics-and referrals.

conclusionsTherefore, the need for a national rare diseases helpline was confirmed in this study. Due to limited financial resources, existing offers should be adapted in a stepwise procedure in accordance with the identified attributes.

Indexed as

Health Services Needs and DemandRare DiseasesTelephoneAdolescentAdultAgedAged, 80 and overCounselingFemaleGermanyHealth PersonnelHumansInterviews as TopicMaleMiddle AgedPatient Education as TopicHealth informationHealth-seeking behaviourHelplineRare diseasesTelemedicine

Identifiers

PMID29426339
PMCPMC5807836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.